株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

自閉症スペクトラム障害(ASD)治療薬の世界市場:医薬品タイプ、適応症、流通チャネル、地域別 - 分析、シェア、動向、市場規模、予測

Autism Spectrum Disorder Therapeutics Market, By Drug Types, By Indication, By Distribution Channel and Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025

発行 AnalystView Market Insights 商品コード 874720
出版日 ページ情報 英文 130 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.52円で換算しております。
Back to Top
自閉症スペクトラム障害(ASD)治療薬の世界市場:医薬品タイプ、適応症、流通チャネル、地域別 - 分析、シェア、動向、市場規模、予測 Autism Spectrum Disorder Therapeutics Market, By Drug Types, By Indication, By Distribution Channel and Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
出版日: 2019年06月01日 ページ情報: 英文 130 Pages
概要

当レポートでは、世界の自閉症スペクトラム障害(ASD)治療薬市場を調査し、市場の概要、医薬品クラス・適応症・流通チャネル・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場シェア、競合情勢、主要企業の分析など、包括的な情報を提供しています。

第1章 市場概要

第2章 エグゼクティブサマリー

  • 市場スニペット:セグメント別
  • 競争考察

第3章 市場動向

  • 成長要因
  • 阻害要因
  • 市場機会
  • 将来動向

第4章 産業分析

  • ファイブフォース分析
  • 市場戦略の分析
  • 成長見通し
  • 規制の枠組み

第5章 市場情勢

  • 市場シェアの分析
  • 主要イノベーター企業
  • 詳細データ:主要製造企業別

第6章 世界の自閉症スペクトラム障害(ASD)治療薬市場:医薬品クラス別

  • 市場概要
  • 睡眠薬
  • 選択的セロトニン再取り込み阻害薬(SSRI)
  • 抗けいれん薬
  • 抗精神病薬
  • その他

第7章 世界の自閉症スペクトラム障害(ASD)治療薬市場:適応症別

  • 市場概要
  • 不眠症
  • てんかん
  • 抑うつ
  • 注意欠陥・多動症
  • その他

第8章 世界の自閉症スペクトラム障害(ASD)治療薬市場:流通チャネル別

  • 市場概要
  • 病院薬局
  • 小売薬局
  • その他

第9章 世界の自閉症スペクトラム障害(ASD)治療薬市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第10章 主要ベンダーの分析

  • Actavis, Inc.
  • Curemark LL
  • Janssen Pharmaceuticals, Inc.
  • 大塚ホールディングス
  • Pediatric BioScience, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Novartis AG
  • Bristol-Myers Squibb
  • Merck & Co.

第11章 全方位分析

第12章 付録

  • 調査手法
  • 参考文献
  • 略語
  • 免責事項
  • 連絡先
図表

List of Tables

  • TABLE List of data Drug Class
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Autism Spectrum Disorder Therapeutics market: Drug Class snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Autism Spectrum Disorder Therapeutics market, by Drug Class, 2014-2025 (USD Million)
  • TABLE Autism Spectrum Disorder Therapeutics market: Indication snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Autism Spectrum Disorder Therapeutics market, by Indication 2014-2025 (USD Million)
  • TABLE Autism Spectrum Disorder Therapeutics market: Distribution Channel snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Autism Spectrum Disorder Therapeutics market, by Distribution Channel 2014-2025 (USD Million)
  • TABLE Autism Spectrum Disorder Therapeutics market: regional snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by region
  • TABLE Global Autism Spectrum Disorder Therapeutics market, by region 2014-2025 (USD Million)
  • TABLE North America Autism Spectrum Disorder Therapeutics market, by country, 2014-2025 (USD Million)
  • TABLE North America Autism Spectrum Disorder Therapeutics market, by Drug Class, 2014-2025 (USD Million)
  • TABLE North America Autism Spectrum Disorder Therapeutics market, by Indication, 2014-2025 (USD Million)
  • TABLE North America Autism Spectrum Disorder Therapeutics market, by Distribution Channel, 2014-2025 (USD Million)
  • TABLE U.S. Autism Spectrum Disorder Therapeutics market, by Drug Class, 2014-2025 (USD Million)
  • TABLE U.S. Autism Spectrum Disorder Therapeutics market, by Indication, 2014-2025 (USD Million)
  • TABLE U.S. Autism Spectrum Disorder Therapeutics market, by Distribution Channel, 2014-2025 (USD Million)
  • TABLE Canada Autism Spectrum Disorder Therapeutics market, by Drug Class, 2014-2025 (USD Million)
  • TABLE Canada Autism Spectrum Disorder Therapeutics market, by Indication, 2014-2025 (USD Million)
  • TABLE Canada Autism Spectrum Disorder Therapeutics market, by Distribution Channel, 2014-2025 (USD Million)
  • TABLE Europe Autism Spectrum Disorder Therapeutics market, by country, 2014-2025 (USD Million)
  • TABLE Europe Autism Spectrum Disorder Therapeutics market, by Drug Class, 2014-2025 (USD Million)
  • TABLE Europe Autism Spectrum Disorder Therapeutics market, by Indication, 2014-2025 (USD Million)
  • TABLE Europe Autism Spectrum Disorder Therapeutics market, by Distribution Channel, 2014-2025 (USD Million)
  • TABLE Germany Autism Spectrum Disorder Therapeutics market, by Drug Class, 2014-2025 (USD Million)
  • TABLE Germany Autism Spectrum Disorder Therapeutics market, by Indication, 2014-2025 (USD Million)
  • TABLE Germany Autism Spectrum Disorder Therapeutics market, by Distribution Channel, 2014-2025 (USD Million)
  • TABLE U.K. Autism Spectrum Disorder Therapeutics market, by Drug Class, 2014-2025 (USD Million)
  • TABLE U.K. Autism Spectrum Disorder Therapeutics market, by Indication, 2014-2025 (USD Million)
  • TABLE U.K. Autism Spectrum Disorder Therapeutics market, by Distribution Channel, 2014-2025 (USD Million)
  • TABLE Rest of the Europe Autism Spectrum Disorder Therapeutics market, by Drug Class, 2014-2025 (USD Million)
  • TABLE Rest of the Europe Autism Spectrum Disorder Therapeutics market, by Indication, 2014-2025 (USD Million)
  • TABLE Rest of the Europe Autism Spectrum Disorder Therapeutics market, by Distribution Channel, 2014-2025 (USD Million)
  • TABLE Asia Pacific Autism Spectrum Disorder Therapeutics market, by country, 2014-2025 (USD Million)
  • TABLE Asia Pacific Autism Spectrum Disorder Therapeutics market, by Drug Class, 2014-2025 (USD Million)
  • TABLE Asia Pacific Autism Spectrum Disorder Therapeutics market, by Indication, 2014-2025 (USD Million)
  • TABLE Asia Pacific Autism Spectrum Disorder Therapeutics market, by Distribution Channel, 2014-2025 (USD Million)
  • TABLE Japan Autism Spectrum Disorder Therapeutics market, by Drug Class, 2014-2025 (USD Million)
  • TABLE Japan Autism Spectrum Disorder Therapeutics market, by Indication, 2014-2025 (USD Million)
  • TABLE Japan Autism Spectrum Disorder Therapeutics market, by Distribution Channel, 2014-2025 (USD Million)
  • TABLE China Autism Spectrum Disorder Therapeutics market, by Drug Class, 2014-2025 (USD Million)
  • TABLE China Autism Spectrum Disorder Therapeutics market, by Indication, 2014-2025 (USD Million)
  • TABLE China Autism Spectrum Disorder Therapeutics market, by Distribution Channel, 2014-2025 (USD Million)
  • TABLE Rest of Asia Pacific Autism Spectrum Disorder Therapeutics market, by Drug Class, 2014-2025 (USD Million)
  • TABLE Rest of Asia Pacific Autism Spectrum Disorder Therapeutics market, by Indication, 2014-2025 (USD Million)
  • TABLE Rest of Asia Pacific Autism Spectrum Disorder Therapeutics market, by Distribution Channel, 2014-2025 (USD Million)
  • TABLE Rest of the World Autism Spectrum Disorder Therapeutics market, by country, 2014-2025 (USD Million)
  • TABLE Rest of the World Autism Spectrum Disorder Therapeutics market, by Drug Class, 2014-2025 (USD Million)
  • TABLE Rest of the World Autism Spectrum Disorder Therapeutics market, by Indication, 2014-2025 (USD Million)
  • TABLE Rest of the World Autism Spectrum Disorder Therapeutics market, by Distribution Channel, 2014-2025 (USD Million)
  • TABLE Latin America Autism Spectrum Disorder Therapeutics market, by Drug Class, 2014-2025 (USD Million)
  • TABLE Latin America Autism Spectrum Disorder Therapeutics market, by Indication, 2014-2025 (USD Million)
  • TABLE Latin America Autism Spectrum Disorder Therapeutics market, by Distribution Channel, 2014-2025 (USD Million)
  • TABLE Middle East and Africa Autism Spectrum Disorder Therapeutics market, by Drug Class, 2014-2025 (USD Million)
  • TABLE Middle East and Africa Autism Spectrum Disorder Therapeutics market, by Indication, 2014-2025 (USD Million)
  • TABLE Middle East and Africa Autism Spectrum Disorder Therapeutics market, by Distribution Channel, 2014-2025 (USD Million)

List of Figures

  • FIGURE Autism Spectrum Disorder Therapeutics market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Drug Class segment market share analysis, 2017 & 2025
  • FIGURE Drug Class segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Insomnia Drugs market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Selective Serotonin Reuptake Inhibitors market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Anticonvulsants market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Antipsychotics market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Indication segment market share analysis, 2017 & 2025
  • FIGURE Indication segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Insomnia market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Epilepsy market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Depression market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Hyperactivity and Inattention market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2017 & 2025
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Hospital pharmacies market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Retail pharmacies market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Regional segment market share analysis, 2017 & 2025
  • FIGURE Regional segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE North America Autism Spectrum Disorder Therapeutics market share and leading players, 2018
  • FIGURE Europe Autism Spectrum Disorder Therapeutics market share and leading players, 2018
  • FIGURE Asia Pacific Autism Spectrum Disorder Therapeutics market share and leading players, 2018
  • FIGURE Latin America Autism Spectrum Disorder Therapeutics market share and leading players, 2018
  • FIGURE Middle East and Africa Autism Spectrum Disorder Therapeutics market share and leading players, 2018
  • FIGURE North America market share analysis by country, 2018
  • FIGURE U.S. market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Canada market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Europe market share analysis by country, 2018
  • FIGURE U.K. market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Germany market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Rest of the Europe market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Asia Pacific market share analysis by country, 2018
  • FIGURE India market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE China market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Rest of Asia Pacific market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Rest of the World market share analysis by country, 2018
  • FIGURE Latin America market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Middle East and Africa market size, forecast and trend analysis, 2014 to 2025 (USD Million)
目次

Title:
Autism Spectrum Disorder Therapeutics Market, By Drug Types (Insomnia Drugs, Selective Serotonin Reuptake Inhibitors, Anticonvulsants, and Antipsychotics), By Indication, By Distribution Channel and Geography (North America, Europe, Asia Pacific, and RoW) - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025.

REPORT HIGHLIGHT

The autism spectrum disorder therapeutics market was valued at USD 2.68 billion by 2017, growing with 3.4% CAGR during the forecast period, 2018-2025.

MARKET DYNAMICS

Autism spectrum disorder includes a class of neuro-developmental disabilities. Some of the prominent disorders that come under the umbrella term of autism spectrum disorder are pervasive personality disorder-not otherwise specified, Asperger's syndrome, and autism. Autism spectrum disorder therapeutics concerns with various treatment options such as behavioral therapy, which is usually considered as the first-line treatment. Patients are also given pharmacological therapies to help them function properly in their daily lives.

Autism spectrum disorder therapeutics companies are observed to continuously introduce innovative solutions in the global market after receiving approval from regulatory authorities. In April 2019, Finch Therapeutics Group, a US developer of microbial therapies, received FDA's Fast Track designation for its Full-Spectrum Microbiota therapy. According to the company, the therapy is aimed at treating autism spectrum disorder in children.

The growing number of autism patients is anticipated to increase the demand for autism spectrum disorder therapeutics. Companies are coming up with various novel products and have a number of drugs in the pipeline for autism treatment. Moreover, there has been a rise in the manufacture of generic pharmaceutical products used to treat autism. All of these factors are expected to push the growth of the global autism spectrum disorder therapeutics market. In addition, companies are investing heavily in research and development to introduce new products in the global market. However, tight regulations and policies associated with product approval are foretold to pose a challenge to players operating in the global autism spectrum disorder therapeutics market.

Drug Type Takeaway

The segment of insomnia drugs is projected to exhibit robust growth in the global autism spectrum disorder therapeutics market. In April 2019, the FDA announced that it will require certain prescription insomnia medicine manufacturers to issue a new boxed warning. The announcement comes after the reporting of several cases of deaths and serious injuries caused due to complex sleep behaviors after taking the medicines. Among indication segments, insomnia could secure a significant share of the global market. Analysts expect hospital pharmacies to collect a leading share of the global market, among distribution channels.

Regional Takeaway

Regionally, North America is forecast to show healthier growth in the global autism spectrum disorder therapeutics market because of the rising awareness about autism, increasing incidence of the disorder, and new product development. Europe could be another high-growth regional market gaining from the increase in research and development activities and rising number of autism awareness programs.

Key Players

The global autism spectrum disorder therapeutics market witnesses the presence of top players such as Actavis, Inc., Curemark LLC, Janssen Pharmaceuticals, Inc., Otsuka Holdings Co., Ltd., Pediatric BioScience, Inc., Teva Pharmaceutical Industries Ltd., Mylan Pharmaceuticals, Inc., Pfizer Inc., Novartis AG, Bristol-Myers Squibb, Merck & Co., and Par Sterile Products, LLC.

The market size and forecast for each segment and sub-segments has been considered as below:

  • Historical Year - 2014 & 2016
  • Base Year - 2017
  • Estimated Year - 2018
  • Projected Year - 2025

TARGET AUDIENCE

  • Traders, Distributors, and Suppliers
  • Manufacturers
  • Government and Regional Agencies
  • Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY DRUG CLASS

  • Insomnia Drugs
  • Selective Serotonin Reuptake Inhibitors
  • Anticonvulsants
  • Antipsychotics
  • Others

MARKET, BY INDICATION

  • Insomnia
  • Epilepsy
  • Depression
  • Hyperactivity and Inattention
  • Others

MARKET, BY DISTRIBUTION CHANNEL

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

MARKET, BY REGION

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of APAC
  • Rest of the World
    • Middle East and Africa
    • Latin America

TABLE OF CONTENT

1. AUTISM SPECTRUM DISORDER THERAPEUTICS MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Drug Class
    • 2.1.2. Market Snippet by Indication
    • 2.1.3. Market Snippet by Distribution Channel
    • 2.1.4. Market Snippet by Region
  • 2.2. Competitive Insights

3. AUTISM SPECTRUM DISORDER THERAPEUTICS KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. AUTISM SPECTRUM DISORDER THERAPEUTICS INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AUTISM SPECTRUM DISORDER THERAPEUTICS MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. AUTISM SPECTRUM DISORDER THERAPEUTICS MARKET - BY DRUG CLASS

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Drug Class, 2017 & 2025 (%)
  • 6.2. Insomnia Drugs
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.3. Selective Serotonin Reuptake Inhibitors
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.4. Anticonvulsants
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.5. Antipsychotics
    • 6.5.1. Overview
    • 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.6. Others
    • 6.6.1. Overview
    • 6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

7. AUTISM SPECTRUM DISORDER THERAPEUTICS MARKET - BY INDICATION

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2017 & 2025 (%)
  • 7.2. Insomnia
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.3. Epilepsy
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.4. Depression
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.5. Hyperactivity and Inattention
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.6. Others
    • 7.6.1. Overview
    • 7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

8. AUTISM SPECTRUM DISORDER THERAPEUTICS MARKET - BY DISTRIBUTION CHANNEL

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Distribution Channel, 2017 & 2025 (%)
  • 8.2. Hospital Pharmacies
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 8.3. Retail Pharmacies
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 8.4. Others
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

9. AUTISM SPECTRUM DISORDER THERAPEUTICS MARKET- BY GEOGRAPHY

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Region, 2017 & 2025 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Drug Class, 2014 - 2025 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Indication, 2014 - 2025 (US$ Million)
    • 9.2.6. North America Market Size and Forecast, By Distribution Channel, 2014 - 2025 (US$ Million)
    • 9.2.7. U.S.
    • 9.2.7.1. Overview
    • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.2.8. Canada
    • 9.2.8.1. Overview
    • 9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Drug Class, 2014 - 2025 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Indication, 2014 - 2025 (US$ Million)
    • 9.3.6. Europe Market Size and Forecast, By Distribution Channel, 2014 - 2025 (US$ Million)
    • 9.3.7. France
    • 9.3.7.1. Overview
    • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.3.8. Germany
    • 9.3.8.1. Overview
    • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.3.9. Rest of Europe
    • 9.3.9.1. Overview
    • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2014 - 2025 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Indication, 2014 - 2025 (US$ Million)
    • 9.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2014 - 2025 (US$ Million)
    • 9.4.7. China
    • 9.4.7.1. Overview
    • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.4.8. India
    • 9.4.8.1. Overview
    • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.4.9. Rest of APAC
    • 9.4.9.1. Overview
    • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 9.5. Rest of the World
    • 9.5.1. Overview
    • 9.5.2. Key Manufacturers in Rest of the World
    • 9.5.3. Rest of the World Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 9.5.4. Rest of the World Market Size and Forecast, By Drug Class, 2014 - 2025 (US$ Million)
    • 9.5.5. Rest of the World Market Size and Forecast, By Indication, 2014 - 2025 (US$ Million)
    • 9.5.6. Rest of the World Market Size and Forecast, By Distribution Channel, 2014 - 2025 (US$ Million)
    • 9.5.7. Latin America
    • 9.5.7.1. Overview
    • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 9.5.8. Middle East and Africa
    • 9.5.8.1. Overview
    • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

10. KEY VENDOR ANALYSIS

  • 10.1. Actavis, Inc.
    • 10.1.1. Company Snapshot
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Strategic Initiatives
  • 10.2. Curemark LLC
    • 10.2.1. Company Snapshot
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Strategic Initiatives
  • 10.3. Janssen Pharmaceuticals, Inc.
    • 10.3.1. Company Snapshot
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Strategic Initiatives
  • 10.4. Otsuka Holdings Co., Ltd.
    • 10.4.1. Company Snapshot
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Strategic Initiatives
  • 10.5. Pediatric BioScience, Inc.
    • 10.5.1. Company Snapshot
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Strategic Initiatives
  • 10.6. Teva Pharmaceutical Industries Ltd.
    • 10.6.1. Company Snapshot
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Strategic Initiatives
  • 10.7. Mylan Pharmaceuticals, Inc.
    • 10.7.1. Company Snapshot
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Strategic Initiatives
  • 10.8. Pfizer Inc.
    • 10.8.1. Company Snapshot
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Strategic Initiatives
  • 10.9. Novartis AG
    • 10.9.1. Company Snapshot
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Strategic Initiatives
  • 10.10. Bristol-Myers Squibb
    • 10.10.1. Company Snapshot
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Strategic Initiatives
  • 10.11. Merck & Co.
    • 10.11.1. Company Snapshot
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Strategic Initiatives
  • 10.12. Par Sterile Products, LLC
    • 10.12.1. Company Snapshot
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Strategic Initiatives

11. 360 DEGREE ANALYSTVIEW

12. APPENDIX

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us
Back to Top